[144] Nova Ltd. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Nova Ltd. (NVMI): The filer reports a proposed sale of 1,281 ordinary shares through Oppenheimer & Co. Inc., listed on Nasdaq, with an aggregate market value of $356,310.15. The filing lists the total number of shares outstanding as 29,278,401 and gives an approximate sale date of 09/11/2025.

The securities to be sold were originally acquired as restricted stock units: 1,605 shares on 06/23/2022, 1,814 shares on 06/23/2022, and 1,704 shares on 05/18/2023. The filer reports no securities sold in the past three months for the account whose sale is proposed. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.

Positive

• Detailed acquisition history provided: acquisition dates and quantities for all RSUs being disclosed
• Broker identified (Oppenheimer & Co. Inc.) and trading venue (Nasdaq) are explicitly stated
• No sales in past three months reported for the account to be sold, clarifying recent activity
• Required attestation included that the seller lacks undisclosed material adverse information

Negative

• None.

Insights

Financial Analyst

TL;DR: Small, routine insider sale notice: 1,281 shares proposed for sale, representing a modest fraction of outstanding stock.

The Form 144 provides explicit details on the proposed sale: broker identity (Oppenheimer & Co.), listed market (Nasdaq), exact share count (1,281) and aggregate market value ($356,310.15). Acquisition history shows all securities originated as restricted stock units issued in mid-2022 and mid-2023 totaling 5,123 awarded shares, of which 1,281 are now proposed for sale. The filing states no sales by the account in the prior three months and includes the required attestation regarding material non-public information. From a valuation perspective, the disclosed aggregate value allows investors to gauge size of the sale relative to outstanding shares, but the form does not include any forward-looking commentary or company performance metrics.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure: the filer documents acquisition origin and uses a registered broker, fulfilling Rule 144 notice requirements.

The filing documents the nature of acquisition (Restricted Stock Units) and lists acquisition dates and amounts, which supports transparency about the seller's holding history. The use of a named broker and the attestation about possession of material non-public information are consistent with expected governance and insider-sale protocols. The form reports no related sales in the previous three months, simplifying aggregation questions under Rule 144. The filing does not state any trading plan adoption date or 10b5-1 plan details.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc 85 Broad Street New York NY 10004	1281	356310.15	29278401	09/11/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	06/23/2022	Restricted Stock Units	Issuer			1605	06/23/2022	N/A
Ordinary	06/23/2022	Restricted Stock Units	Issuer			1814	06/23/2022	N/A
Ordinary	05/18/2023	Restricted Stock Units	Issuer			1704	05/18/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for NVMI disclose about the proposed sale?

The form discloses a proposed sale of 1,281 ordinary shares with an aggregate market value of $356,310.15 through Oppenheimer & Co. Inc. on Nasdaq, approximately on 09/11/2025.

How many shares outstanding does Nova Ltd. (NVMI) report on this filing?

The filing reports 29,278,401 shares outstanding.

What is the origin of the securities to be sold according to the filing?

All disclosed securities were acquired as Restricted Stock Units: 1,605 and 1,814 on 06/23/2022, and 1,704 on 05/18/2023.

Does the Form 144 report any securities sold in the past three months?

No. The filing explicitly states "Nothing to Report" for securities sold during the past three months by the account to be sold.

Does the filing include any statement about material non-public information?

Yes. The filer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.